Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: Phase 2 study results […]Read More… from Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: Phase 2 study results
The Interleukin-11/IL-11 Receptor Promotes Glioblastoma Survival and Invasion under Glucose-Starved Conditions through Enhanced Glutaminolysis. […]Read More… from The Interleukin-11/IL-11 Receptor Promotes Glioblastoma Survival and Invasion under Glucose-Starved Conditions through Enhanced Glutaminolysis.
Low-Dose Palliative Chemotherapy Compared to Standard-Dose Chemotherapy for Poor-Prognosis Cancers Improves Overall Survival- A Single Institution Study. […]Read More… from Low-Dose Palliative Chemotherapy Compared to Standard-Dose Chemotherapy for Poor-Prognosis Cancers Improves Overall Survival- A Single Institution Study.
Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytes […]Read More… from Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytes
Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study […]Read More… from Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study
When Langerhans met Crohn- intestinal inflammation in disguise […]Read More… from When Langerhans met Crohn- intestinal inflammation in disguise
Foxp3+ Tregs from Langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacity […]Read More… from Foxp3+ Tregs from Langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacity
Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric Cancer […]Read More… from Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric Cancer
Altered Populations of Unconventional T Cell Lineages in Patients with Langerhans Cell Histiocytosis […]Read More… from Altered Populations of Unconventional T Cell Lineages in Patients with Langerhans Cell Histiocytosis
A potentially important role for T cells and regulatory T cells in Langerhans cell histiocytosis […]Read More… from A potentially important role for T cells and regulatory T cells in Langerhans cell histiocytosis
Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma. […]Read More… from Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma.
Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling […]Read More… from Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14 […]Read More… from Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer […]Read More… from Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Evaluation of response from axitinib per Response Evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma. […]Read More… from Evaluation of response from axitinib per Response Evaluation Criteria in Solid Tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma.
Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial. […]Read More… from Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.
Resolution of norfloxacin-induced acute liver failure after N-acetylcysteine therapy: further support for the use of NAC in drug-induced ALF? […]Read More… from Resolution of norfloxacin-induced acute liver failure after N-acetylcysteine therapy: further support for the use of NAC in drug-induced ALF?
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial. […]Read More… from Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
Suppression subtractive hybridization method for the identification of a new strain of murine hepatitis virus from xenografted SCID mice. […]Read More… from Suppression subtractive hybridization method for the identification of a new strain of murine hepatitis virus from xenografted SCID mice.
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma. […]Read More… from EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma.
Polyclonal T-cells express CD1a in Langerhans cell histiocytosis (LCH) lesions. […]Read More… from Polyclonal T-cells express CD1a in Langerhans cell histiocytosis (LCH) lesions.
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. […]Read More… from Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial. […]Read More… from Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial.
Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem) […]Read More… from Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. […]Read More… from Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Breast-cancer adjuvant therapy with zoledronic acid. […]Read More… from Breast-cancer adjuvant therapy with zoledronic acid.
Adjuvant trastuzumab in HER2-positive breast cancer. […]Read More… from Adjuvant trastuzumab in HER2-positive breast cancer.
A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes. […]Read More… from A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report. […]Read More… from The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report.
Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. […]Read More… from Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia.
Three cases of activation of cutaneous squamous-cell carcinoma during treatment with prolonged administration of rituximab. […]Read More… from Three cases of activation of cutaneous squamous-cell carcinoma during treatment with prolonged administration of rituximab.
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. […]Read More… from The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.
Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. […]Read More… from Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
A time to kill: viral manipulation of the cell death program. […]Read More… from A time to kill: viral manipulation of the cell death program.
Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. […]Read More… from Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.
Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. […]Read More… from Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy.
Novel endogenous type D retroviral particles expressed at high levels in a SCID mouse thymic lymphoma. […]Read More… from Novel endogenous type D retroviral particles expressed at high levels in a SCID mouse thymic lymphoma.
Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions. […]Read More… from Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions.
Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. […]Read More… from Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle.
EWS/FLI-1 fusion transcript detection and MIC2 immunohistochemical staining in the diagnosis of Ewing’s sarcoma. […]Read More… from EWS/FLI-1 fusion transcript detection and MIC2 immunohistochemical staining in the diagnosis of Ewing’s sarcoma.
Cytogenetic and DNA analysis of two neuroectodermal tumors without a simple t(11;22). […]Read More… from Cytogenetic and DNA analysis of two neuroectodermal tumors without a simple t(11;22).
Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. […]Read More… from Soluble antigen can cause enhanced apoptosis of germinal-centre B cells.
bcl-2 transgene expression can protect neurons against developmental and induced cell death. […]Read More… from bcl-2 transgene expression can protect neurons against developmental and induced cell death.
Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursor acute lymphoblastic leukemic cells. […]Read More… from Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursor acute lymphoblastic leukemic cells.
Flow cytometric analysis of intercellular adhesion between B-cell precursor acute lymphoblastic leukemic cells and bone marrow stromal cells. […]Read More… from Flow cytometric analysis of intercellular adhesion between B-cell precursor acute lymphoblastic leukemic cells and bone marrow stromal cells.
Kiz-1, a protein with LIM zinc finger and kinase domains, is expressed mainly in neurons […]Read More… from Kiz-1, a protein with LIM zinc finger and kinase domains, is expressed mainly in neurons
The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. […]Read More… from The role of cytokines in the pathogenesis of Langerhans cell histiocytosis.
The biology of erythropoietin and its role in the anaemia of prematurity […]Read More… from The biology of erythropoietin and its role in the anaemia of prematurity
Human bone marrow stromal cell contact and soluble factors have different effects on the survival and proliferation of paediatric B-lineage acute lymphoblastic leukaemic blasts. […]Read More… from Human bone marrow stromal cell contact and soluble factors have different effects on the survival and proliferation of paediatric B-lineage acute lymphoblastic leukaemic blasts.
Dose-intensive cyclophosphamide with etoposide and vincristine for pediatric solid tumors: a phase I/II pilot study by the Australia and New Zealand Childhood Cancer Study Group […]Read More… from Dose-intensive cyclophosphamide with etoposide and vincristine for pediatric solid tumors: a phase I/II pilot study by the Australia and New Zealand Childhood Cancer Study Group
Measurement of the growth parameters of precursor B-acute lymphoblastic leukaemic cells in co-culture with bone marrow stromal cells; detection of two cd10 positive populations with different proliferative capacities and survival. […]Read More… from Measurement of the growth parameters of precursor B-acute lymphoblastic leukaemic cells in co-culture with bone marrow stromal cells; detection of two cd10 positive populations with different proliferative capacities and survival.
A novel approach to the measurement of different in vitro leukaemic cell growth parameters: the use of PKH GL fluorescent probes. […]Read More… from A novel approach to the measurement of different in vitro leukaemic cell growth parameters: the use of PKH GL fluorescent probes.
Characterization of stroma-adherent colony-forming cells: a clonogenic assay for early hemopoietic cells? […]Read More… from Characterization of stroma-adherent colony-forming cells: a clonogenic assay for early hemopoietic cells?
Proliferative properties of unfractionated, purified, and single cell human progenitor populations stimulated by recombinant human interleukin-3 […]Read More… from Proliferative properties of unfractionated, purified, and single cell human progenitor populations stimulated by recombinant human interleukin-3
Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. […]Read More… from Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients.
Enhancement of in vitro beta-thalassemic and normal hematopoiesis by a noncytotoxic monoclonal antibody, 9.1C3: evidence for negative regulation of hematopoiesis by monocytes and natural killer cells. […]Read More… from Enhancement of in vitro beta-thalassemic and normal hematopoiesis by a noncytotoxic monoclonal antibody, 9.1C3: evidence for negative regulation of hematopoiesis by monocytes and natural killer cells.
Pharmacokinetics of human granulocyte-macrophage colony-stimulating factor using a sensitive immunoassay […]Read More… from Pharmacokinetics of human granulocyte-macrophage colony-stimulating factor using a sensitive immunoassay
Clinical studies with granulocyte colony stimulating factor (G-CSF) in patients receiving cytotoxic chemotherapy. […]Read More… from Clinical studies with granulocyte colony stimulating factor (G-CSF) in patients receiving cytotoxic chemotherapy.
Activated killer cell lymphoma: an erythrophagocytic syndrome simulating histiocytic medullary histiocytosis. […]Read More… from Activated killer cell lymphoma: an erythrophagocytic syndrome simulating histiocytic medullary histiocytosis.
Clonal proliferation in vitro of individual murine and human hemopoietic cells after fluorescence-activated cell sorting. […]Read More… from Clonal proliferation in vitro of individual murine and human hemopoietic cells after fluorescence-activated cell sorting.
Evidence for interactions between monocytes and natural killer cells in the regulation of in vitro hemopoiesis […]Read More… from Evidence for interactions between monocytes and natural killer cells in the regulation of in vitro hemopoiesis
Fractionation of subsets of BFU-E from normal human bone marrow: responsiveness to erythropoietin, human placental-conditioned medium, or granulocyte-macrophage colony-stimulating factor. […]Read More… from Fractionation of subsets of BFU-E from normal human bone marrow: responsiveness to erythropoietin, human placental-conditioned medium, or granulocyte-macrophage colony-stimulating factor.
A human complement-fixing monoclonal anti-human lymphocyte antibody of rat origin. […]Read More… from A human complement-fixing monoclonal anti-human lymphocyte antibody of rat origin.
Fractionation of normal and beta-thalassemic human hemopoietic progenitor cells by immunomagnetic beads. […]Read More… from Fractionation of normal and beta-thalassemic human hemopoietic progenitor cells by immunomagnetic beads.
Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. […]Read More… from Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage.
Studies by radioiodination of normal adult, fetal and leukemic cell membranes. […]Read More… from Studies by radioiodination of normal adult, fetal and leukemic cell membranes.
Osmotic fragility of leukaemic and normal lymphocytes […]Read More… from Osmotic fragility of leukaemic and normal lymphocytes
Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer […]Read More… from Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer
Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes […]Read More… from Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes
Determinants of Resistance to VEGF-TKI and Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma […]Read More… from Determinants of Resistance to VEGF-TKI and Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma
In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell Carcinoma. […]Read More… from In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell Carcinoma.
Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism […]Read More… from Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism
Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment […]Read More… from Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment
Adjuvant Ovarian Suppression in Premenopausal Breast Cancer […]Read More… from Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells […]Read More… from TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells
Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods […]Read More… from Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods
Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer. […]Read More… from Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer.
Tumour Microenvironment and Metabolic Plasticity in Cancer and Cancer Stem Cells: Perspectives on Metabolic and Immune Regulatory Signatures in Chemoresistant Ovarian Cancer Stem Cells. […]Read More… from Tumour Microenvironment and Metabolic Plasticity in Cancer and Cancer Stem Cells: Perspectives on Metabolic and Immune Regulatory Signatures in Chemoresistant Ovarian Cancer Stem Cells.
Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer. […]Read More… from Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer.
The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression. […]Read More… from The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.
Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer. […]Read More… from Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer.
Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells […]Read More… from Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
The role of pregnancy associated plasma protein-A in triple negative breast cancer: a promising target for achieving clinical benefits […]Read More… from The role of pregnancy associated plasma protein-A in triple negative breast cancer: a promising target for achieving clinical benefits
The Role of TIM-3 in Glioblastoma Progression […]Read More… from The Role of TIM-3 in Glioblastoma Progression
Use of Suppression Subtractive Hybridization for Viral Diagnostics […]Read More… from Use of Suppression Subtractive Hybridization for Viral Diagnostics
Advances in CRISPR/Cas systems-based cell and gene therapy […]Read More… from Advances in CRISPR/Cas systems-based cell and gene therapy
Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer […]Read More… from Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer
Does CD1a Expression Influence T Cell Function in Patients With Langerhans Cell Histiocytosis? […]Read More… from Does CD1a Expression Influence T Cell Function in Patients With Langerhans Cell Histiocytosis?
Langerhans cell histiocytosis: A malignant myeloid neoplasm or disorder of immune regulation? […]Read More… from Langerhans cell histiocytosis: A malignant myeloid neoplasm or disorder of immune regulation?
A Role for MAIT Cells in Colorectal Cancer […]Read More… from A Role for MAIT Cells in Colorectal Cancer
Chronically stimulated human MAIT cells are unexpectedly potent IL-13 producers […]Read More… from Chronically stimulated human MAIT cells are unexpectedly potent IL-13 producers
An emerging role for immune regulatory subsets in chronic lymphocytic leukaemia. […]Read More… from An emerging role for immune regulatory subsets in chronic lymphocytic leukaemia.
The glucocorticoid receptor 1A3 promoter correlates with high sensitivity to glucocorticoid-induced apoptosis in human lymphocytes. […]Read More… from The glucocorticoid receptor 1A3 promoter correlates with high sensitivity to glucocorticoid-induced apoptosis in human lymphocytes.
Acute exercise leads to regulation of telomere-associated genes and microRNA expression in immune cells. […]Read More… from Acute exercise leads to regulation of telomere-associated genes and microRNA expression in immune cells.
Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas: Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment […]Read More… from Enhanced Expression of Mitochondrial Magmas Protein in Ovarian Carcinomas: Magmas Inhibition Facilitates Antitumour Effects, Signifying a Novel Approach for Ovarian Cancer Treatment
Correlation of Galectin Family Expression with Glioblastoma Progression and Survival […]Read More… from Correlation of Galectin Family Expression with Glioblastoma Progression and Survival
Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation […]Read More… from Reduced T and NK Cell Activity in Glioblastoma Patients Correlates with TIM-3 and BAT3 Dysregulation
Impact of Ligand Concentration on the Properties of Nucleic-Acid-Encapsulated MOFs and Inflammation Modulation in Prostate Cancer Cells […]Read More… from Impact of Ligand Concentration on the Properties of Nucleic-Acid-Encapsulated MOFs and Inflammation Modulation in Prostate Cancer Cells
A three-stage developmental pathway for human Vγ9Vδ2 T cells within the postnatal thymus […]Read More… from A three-stage developmental pathway for human Vγ9Vδ2 T cells within the postnatal thymus
Divergent molecular networks program functionally distinct CD8+ skin-resident memory T cells […]Read More… from Divergent molecular networks program functionally distinct CD8+ skin-resident memory T cells
Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma […]Read More… from Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma
Plasma Signaling Factors in Patients With Langerhans Cell Histiocytosis (LCH) Correlate With Relative Frequencies of LCH Cells and T Cells Within Lesions […]Read More… from Plasma Signaling Factors in Patients With Langerhans Cell Histiocytosis (LCH) Correlate With Relative Frequencies of LCH Cells and T Cells Within Lesions
Patients with both Langerhans cell histiocytosis and Crohn’s disease highlight a common role of interleukin-23 […]Read More… from Patients with both Langerhans cell histiocytosis and Crohn’s disease highlight a common role of interleukin-23
Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience […]Read More… from Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer […]Read More… from Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer […]Read More… from Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer […]Read More… from Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer […]Read More… from Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer […]Read More… from Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence […]Read More… from The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence
Interleukin-11/IL-11 Receptor Promotes Glioblastoma Cell Proliferation, Epithelial-Mesenchymal Transition, and Invasion […]Read More… from Interleukin-11/IL-11 Receptor Promotes Glioblastoma Cell Proliferation, Epithelial-Mesenchymal Transition, and Invasion
Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial-Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico Datasets […]Read More… from Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial-Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico Datasets
Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia […]Read More… from Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia
Synthetic Biology in Precision Medicine and Nanotechnology […]Read More… from Synthetic Biology in Precision Medicine and Nanotechnology
Recent Developments in Single-Cell Transcriptomics […]Read More… from Recent Developments in Single-Cell Transcriptomics
Nanotechnology in the Generation and Analysis of Single Cells […]Read More… from Nanotechnology in the Generation and Analysis of Single Cells
Interplay Between Immune Checkpoint Modulators and the Epithelial-to-Mesenchymal Transition Axis in Clear Cell Renal Cell Carcinoma […]Read More… from Interplay Between Immune Checkpoint Modulators and the Epithelial-to-Mesenchymal Transition Axis in Clear Cell Renal Cell Carcinoma
The Signaling Networks of TIM-3, TGF-β and STING in Glioblastoma […]Read More… from The Signaling Networks of TIM-3, TGF-β and STING in Glioblastoma
Epithelial-to-mesenchymal transition as a robust biomarker and a novel strategy to enhance response to immune checkpoint blockade and targeted therapy in patients with metastatic renal cell carcinoma […]Read More… from Epithelial-to-mesenchymal transition as a robust biomarker and a novel strategy to enhance response to immune checkpoint blockade and targeted therapy in patients with metastatic renal cell carcinoma
Collaboration of Epithelial Mesenchymal Transition and Cancer Stem Cells: Sinister Routes for Chemoresistant Recurrent Ovarian Cancer […]Read More… from Collaboration of Epithelial Mesenchymal Transition and Cancer Stem Cells: Sinister Routes for Chemoresistant Recurrent Ovarian Cancer
Momelotinib reduces cancer stem cell load leading to a decreased tumor burden and a prolonged disease-free remission period in a mouse model of human ovarian cancer […]Read More… from Momelotinib reduces cancer stem cell load leading to a decreased tumor burden and a prolonged disease-free remission period in a mouse model of human ovarian cancer
Murine hepatitis virus RNA, complete genome, strain: MHV-MI […]Read More… from Murine hepatitis virus RNA, complete genome, strain: MHV-MI
A method for the treatment of tumours and sarcomas […]Read More… from A method for the treatment of tumours and sarcomas
Cellular and humoral interactions in haemopoiesis […]Read More… from Cellular and humoral interactions in haemopoiesis
Characterization of interleukin-3 and granulocyte-macrophage receptors on normal human hemopoietic cells […]Read More… from Characterization of interleukin-3 and granulocyte-macrophage receptors on normal human hemopoietic cells
Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion […]Read More… from Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer […]Read More… from Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer
Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion […]Read More… from Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion
Mechanisms of Immune Cell Dysregulation in Pancreatic Ductal Adenocarcinoma […]Read More… from Mechanisms of Immune Cell Dysregulation in Pancreatic Ductal Adenocarcinoma
Professor George KannourakisProfessor George Kannourakis
Professor George Kannourakis